NCT00963911 · REGISTRY CONDITION SEARCH
Validation of a Screening Tool in Geriatric Oncology
Found through the registry condition index, not selected as a treatment recommendation. This discovery collection was restricted to studies with posted results.
- Phase
- NA
- Status at capture
- COMPLETED
- Registry last update
- 2021-04-05
RATIONALE: A screening questionnaire may help doctors plan better treatment for older patients with cancer. PURPOSE: This clinical trial is studying a questionnaire in screening older patients with cancer.
Open the original ClinicalTrials.gov record → · Download preserved record
What did the study report?
Outcomes, safety and baseline populations are separate source sections. Quality-of-life measures appear under their original outcome titles.
Participant flow
Baseline characteristics
Sensitivity of the G8 Questionnaire
Specificity of the G8 Questionnaire
Sensitivity of the VES-13 Questionnaire
Specificity of the VES-13 Questionnaire
Reproducibility of the G8 Questionnaire
Reproducibility of the VES-13 Questionnaire
Adverse events
Limitations, agreements, and source contact
Who could take part
- eligibility Criteria
- DISEASE CHARACTERISTICS: * Histologically confirmed cancer including the following types: * Colon * Rectal * Lung * Squamous cell carcinoma of the head and neck * Breast * Prostate * Non-Hodgkin lymphoma * Planning to undergo first-time treatment comprising medicine, surgery, or radiotherapy PATIENT CHARACTERISTICS: * No persons deprived of liberty or under guardianship * No psychological, familial, social, or geographical reasons that would make monitoring clinically impossible PRIOR CONCURRENT THERAPY: * See Disease Characteristics
- healthy Volunteers
- false
- maximum Age
- 120 Years
- minimum Age
- 70 Years
- sex
- ALL
- std Ages
- OLDER_ADULT
Treatment arms and interventions
- arm Groups
- description
- Screening tests (G8 and VES-13)
- intervention Names
- Other: Geriatric screening tests
- Other: Multidimensional geriatric assessment
- label
- Included patients
- type
- EXPERIMENTAL
- interventions
- arm Group Labels
- Included patients
- description
- The G-8 consists of eight items: patient age (\>85, 80-85, \<80), and seven items from the original 18-item MNA (Mini Nutritional Assessment: appetite changes, weight loss, mobility, neuropsychological problems, body mass index, medication, and self-rated health). The total score ranges from 0 to 17, with lower scores indicating a higher risk of impairments. The cut-off value for an 'impaired' reference test score was \<=14 and the time taken to complete the test was recorded. VES-13 is a self-administered questionnaire that was completed during the first visit after enrollment. For three pre-identified centers, patients also filled in the questionnaire at the following geriatric visit. VES-13 consisted of four groups of questions: age, self-perceived health, difficulties to perform six specific activities, and difficulties to perform daily living tasks due to health concerns. The score ranged from 0 to 10 and a score \>=3 was considered to show impairment.
- name
- Geriatric screening tests
- other Names
- G-8
- type
- OTHER
- arm Group Labels
- Included patients
- description
- Patients underwent a geriatric evaluation in the month following the completion of G8 and VES-13 (+/- seven days) before treatment began. The nurse completed six of the seven instruments of the MGA (MNA, Timed Get up and Go (TUG), Activities of Daily Living (ADL), Instrumental ADL (IADL), Mini Mental State Examination (MMSE), and Geriatric Depression Scale (GDS-15)), and the geriatrician rated comorbidity on the Cumulative Illness Rating Scale (CIRS-G), recorded the time required for the consultation, identified patients who needed personalized geriatric interventions, and, if necessary, proposed further geriatric evaluation (outside of the scope of this study).
- name
- Multidimensional geriatric assessment
- other Names
- MGA
- type
- OTHER
Study design
- allocation
- NA
- intervention Model
- SINGLE_GROUP
- masking Info
- masking
- NONE
- primary Purpose
- SCREENING
Enrollment
- count
- 1674
- type
- ACTUAL
Registered outcome plans (not posted results)
- primary Outcomes
- description
- Sensitivity of the G8 questionnaire measured as Percentage of Participants with a Positive G8 among patients with a positive MGA. The G8 consists of eight items: patient age (\>85, 80-85, \<80), and seven items from the original 18-item MNA (Mini Nutritional Assessment: appetite changes, weight loss, mobility, neuropsychological problems, body mass index, medication, and self-rated health). The total score ranges from 0 to 17, with lower scores indicating a higher risk of impairments. The cut-off value for an 'impaired' reference test score was \<=14. Multidimensional geriatric assessment (MGA): Patients underwent a geriatric evaluation in the month following the completion of VES-13. The nurse completed six instruments of the MGA (MNA, Timed Get up and Go, Activities of Daily Living (ADL), Instrumental ADL, Mini Mental State Examination, and Geriatric Depression Scale, and the geriatrician rated comorbidity on the Cumulative Illnes Rating Scale.
- measure
- Sensitivity of the G8 Questionnaire
- time Frame
- at inclusion (at completion of the G8 questionnaire)
- secondary Outcomes
- description
- Specificity of the G8 questionnaire measured as percentage of participants with a negative G8 test among patients with a negative MGA.The G8 consists of eight items: patient age (\>85, 80-85, \<80), and seven items from the original 18-item MNA (Mini Nutritional Assessment: appetite changes, weight loss, mobility, neuropsychological problems, body mass index, medication, and self-rated health). The total score ranges from 0 to 17, with lower scores indicating a higher risk of impairments. The cut-off value for an 'impaired' reference test score was \<=14. Multidimensional geriatric assessment (MGA): Patients underwent a geriatric evaluation in the month following the completion of VES-13. The nurse completed six instruments of the MGA (MNA, Timed Get up and Go, Activities of Daily Living (ADL), Instrumental ADL, Mini Mental State Examination, and Geriatric Depression Scale, and the geriatrician rated comorbidity on the Cumulative Illnes Rating Scale.
- measure
- Specificity of the G8 Questionnaire
- time Frame
- at inclusion (at completion of the G8 questionnaire)
- description
- Sensitivity of the VES-13 questionnaire measured as percentage of participants with a positive VES-13 test among patients with a positive MGA. VES-13 is a self-administered questionnaire that was completed during the first visit after enrollment. For 3 pre-identified centers, patients filled in the questionnaire at the following geriatric visit. VES-13 consisted of 4 groups of questions: age, self-perceived health, difficulties to perform 6 specific activities, and difficulties to perform daily living tasks due to health concerns. The score ranged from 0 to 10 and a score \>=3 was considered to show impairment. Multidimensional geriatric assessment (MGA): see measure description for primary outcome.
- measure
- Sensitivity of the VES-13 Questionnaire
- time Frame
- at inclusion
- description
- Specificity of the VES-13 questionnaire measure as the percentage of participants with a negative VES-13 test among patients with a negative MGA. VES-13 is a self-administered questionnaire that was completed during the first visit after enrollment. For 3 pre-identified centers, patients filled in the questionnaire at the following geriatric visit. VES-13 consisted of 4 groups of questions: age, self-perceived health, difficulties to perform 6 specific activities, and difficulties to perform daily living tasks due to health concerns. The score ranged from 0 to 10 and a score \>=3 was considered to show impairment. Multidimensional geriatric assessment (MGA): see measure description for primary outcome.
- measure
- Specificity of the VES-13 Questionnaire
- time Frame
- at inclusion (at completion of the G8 questionnaire)
- description
- Reproducibility of G8 was assessed by comparing the score on the actual G8 with the scores extracted from the corresponding seven questions of MNA completed during the MGA for all patients. The G8 consists of eight items: patient age (\>85, 80-85, \<80), and seven items from the original 18-item MNA (Mini Nutritional Assessment: appetite changes, weight loss, mobility, neuropsychological problems, body mass index, medication, and self-rated health). The total score ranges from 0 to 17, with lower scores indicating a higher risk of impairments. The cut-off value for an 'impaired' reference test score was \<=14.
- measure
- Reproducibility of the G8 Questionnaire
- time Frame
- at inclusion (at completion of the G8 questionnaire)
- description
- Reproducibility of VES-13 was assessed based on a subgroup of patients included in three pre-identified centers who completed the questionnaire on two occasions. VES-13 is a self-administered questionnaire that was completed during the first visit after enrollment. For 3 pre-identified centers, patients filled in the questionnaire at the following geriatric visit. VES-13 consisted of 4 groups of questions: age, self-perceived health, difficulties to perform 6 specific activities, and difficulties to perform daily living tasks due to health concerns. The score ranged from 0 to 10 and a score \>=3 was considered to show impairment.
- measure
- Reproducibility of the VES-13 Questionnaire
- time Frame
- at inclusion (at completion of the G8 questionnaire)
Full study description
- brief Summary
- RATIONALE: A screening questionnaire may help doctors plan better treatment for older patients with cancer. PURPOSE: This clinical trial is studying a questionnaire in screening older patients with cancer.
- detailed Description
- OBJECTIVES: Primary * Validate a new screening tool (G8). Secondary * Validate the French version of the screening tool "Vulnerable Elders Survey (VES-13)". * Evaluate the merits of the screening tools (G8 and VES-13). * Assess the screening tool in specific populations. * Assess the number and type of interventions proposed after thorough geriatric assessment. * Compare the two new tools (G8 vs VES-13). OUTLINE: This is a multicenter study. During the first consultation, patients have an initial clinical evaluation questionnaire comprising the G8. They also complete the self-questionnaire VES-13. Within 30 days, patients have a thorough geriatric assessment, including quality of life and physical function, by a physician without access to the G8 or VES-13 questionnaires. A blood specimen is also collected. Information on health status and quality of life is collected from medical records or from the doctor after 1 and 5 years.
Source references
- references
- citation
- Bellera CA, Artaud F, Rainfray M, Soubeyran PL, Mathoulin-Pelissier S. Modeling individual and relative accuracy of screening tools in geriatric oncology. Ann Oncol. 2017 May 1;28(5):1152-1157. doi: 10.1093/annonc/mdx068.
- pmid
- 28327973
- type
- BACKGROUND
- citation
- Soubeyran P, Bellera C, Goyard J, Heitz D, Cure H, Rousselot H, Albrand G, Servent V, Jean OS, van Praagh I, Kurtz JE, Perin S, Verhaeghe JL, Terret C, Desauw C, Girre V, Mertens C, Mathoulin-Pelissier S, Rainfray M. Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study. PLoS One. 2014 Dec 11;9(12):e115060. doi: 10.1371/journal.pone.0115060. eCollection 2014.
- pmid
- 25503576
- type
- RESULT
Source notices and limitations
Discovery and provenance
- release id
- ctgov-registry-1336d216cbd1bbff780dac70
- edge id
- nct-edge-21e98907337a75a2a809
- requested nct id
- NCT00963911
- primary nct id
- NCT00963911
- source kind
- ctgov_condition_query
- source record id
- Source null
- source file sha256
- cd92c144c33b33e75a38086ce6cbd6e62d34b7ba84c72dacac16e6781439e40e
- payload sha256
- f173858b7de3adf6d42f364f1bcf3ffe612067bb3b9f76ef427b26ac54144ed2
- payload
- clinical indication matching status
- condition_index_match_asserted_by_registry_not_reviewed
- end exclusive
- true
- id
- nct-edge-21e98907337a75a2a809
- link basis
- returned_by_explicit_condition_and_posted_results_filter_query
- nct id
- NCT00963911
- occurrences
- context exact
- NCT00963911
- end
- 11
- exact text
- NCT00963911
- start
- 0
- offset unit
- unicode_code_points
- query cond
- Hypopharyngeal Cancer
- query disease state id
- ds-hypopharyngeal-cancer
- source file
- /Users/arunverma/Documents/ChatGPT/Cancer Statistics Website/research-data/2026-09-10/clinicaltrials-condition/round-0000/raw/cond-hypopharyngeal-cancer-000.json
- source file sha256
- cd92c144c33b33e75a38086ce6cbd6e62d34b7ba84c72dacac16e6781439e40e
- source json pointer
- /studies/47/protocolSection/identificationModule/nctId
- source kind
- ctgov_condition_query
- source record id
- Source null
- source string basis
- parsed_JSON_string_unmodified
- source string sha256
- a5f4c21c7440e4836a8d3b38dc465d5869d97bcb688cdade3a1615717abfca44
- release id
- ctgov-registry-1336d216cbd1bbff780dac70
- edge id
- nct-edge-6dad81c9d2cb943cda31
- requested nct id
- NCT00963911
- primary nct id
- NCT00963911
- source kind
- ctgov_condition_query
- source record id
- Source null
- source file sha256
- fd31a95088dd8ee475e2862bffd724180f0c754cf3f0e892cba5b448df424980
- payload sha256
- bc6c37ea50fc02bb5df50890408d3c93cbbfd0474f967bd7760abe51f5480643
- payload
- clinical indication matching status
- condition_index_match_asserted_by_registry_not_reviewed
- end exclusive
- true
- id
- nct-edge-6dad81c9d2cb943cda31
- link basis
- returned_by_explicit_condition_and_posted_results_filter_query
- nct id
- NCT00963911
- occurrences
- context exact
- NCT00963911
- end
- 11
- exact text
- NCT00963911
- start
- 0
- offset unit
- unicode_code_points
- query cond
- Laryngeal Cancer
- query disease state id
- ds-laryngeal-cancer
- source file
- /Users/arunverma/Documents/ChatGPT/Cancer Statistics Website/research-data/2026-09-10/clinicaltrials-condition/round-0000/raw/cond-laryngeal-cancer-000.json
- source file sha256
- fd31a95088dd8ee475e2862bffd724180f0c754cf3f0e892cba5b448df424980
- source json pointer
- /studies/60/protocolSection/identificationModule/nctId
- source kind
- ctgov_condition_query
- source record id
- Source null
- source string basis
- parsed_JSON_string_unmodified
- source string sha256
- a5f4c21c7440e4836a8d3b38dc465d5869d97bcb688cdade3a1615717abfca44
- release id
- ctgov-registry-1336d216cbd1bbff780dac70
- edge id
- nct-edge-9af22c403b0873d70b0b
- requested nct id
- NCT00963911
- primary nct id
- NCT00963911
- source kind
- ctgov_condition_query
- source record id
- Source null
- source file sha256
- 38e97f6c23d7b292911d062dea3fc0dffbdcbde03aae232fe8d067fdd28034c9
- payload sha256
- f6839335b7d8ed57273206653e622555bab97841dd10cd720a24d4018d36bd0e
- payload
- clinical indication matching status
- condition_index_match_asserted_by_registry_not_reviewed
- end exclusive
- true
- id
- nct-edge-9af22c403b0873d70b0b
- link basis
- returned_by_explicit_condition_and_posted_results_filter_query
- nct id
- NCT00963911
- occurrences
- context exact
- NCT00963911
- end
- 11
- exact text
- NCT00963911
- start
- 0
- offset unit
- unicode_code_points
- query cond
- Salivary Gland Cancer
- query disease state id
- ds-salivary-gland-cancer
- source file
- /Users/arunverma/Documents/ChatGPT/Cancer Statistics Website/research-data/2026-09-10/clinicaltrials-condition/round-0000/raw/cond-salivary-gland-cancer-000.json
- source file sha256
- 38e97f6c23d7b292911d062dea3fc0dffbdcbde03aae232fe8d067fdd28034c9
- source json pointer
- /studies/31/protocolSection/identificationModule/nctId
- source kind
- ctgov_condition_query
- source record id
- Source null
- source string basis
- parsed_JSON_string_unmodified
- source string sha256
- a5f4c21c7440e4836a8d3b38dc465d5869d97bcb688cdade3a1615717abfca44
- release id
- ctgov-registry-1336d216cbd1bbff780dac70
- edge id
- nct-edge-c7feba164d8a3e62c2f9
- requested nct id
- NCT00963911
- primary nct id
- NCT00963911
- source kind
- ctgov_condition_query
- source record id
- Source null
- source file sha256
- 69c40ed34b17434f684079ec5635264bc5ad292871a86b835704fc99fa9d8157
- payload sha256
- 883faa5faeeb26ad3bcec95fb83d0863d4fccb3733a909ed30e4368153d5086a
- payload
- clinical indication matching status
- condition_index_match_asserted_by_registry_not_reviewed
- end exclusive
- true
- id
- nct-edge-c7feba164d8a3e62c2f9
- link basis
- returned_by_explicit_condition_and_posted_results_filter_query
- nct id
- NCT00963911
- occurrences
- context exact
- NCT00963911
- end
- 11
- exact text
- NCT00963911
- start
- 0
- offset unit
- unicode_code_points
- query cond
- Small Intestine Cancer
- query disease state id
- ds-small-intestine-cancer
- source file
- /Users/arunverma/Documents/ChatGPT/Cancer Statistics Website/research-data/2026-09-10/clinicaltrials-condition/round-0000/raw/cond-small-intestine-cancer-000.json
- source file sha256
- 69c40ed34b17434f684079ec5635264bc5ad292871a86b835704fc99fa9d8157
- source json pointer
- /studies/50/protocolSection/identificationModule/nctId
- source kind
- ctgov_condition_query
- source record id
- Source null
- source string basis
- parsed_JSON_string_unmodified
- source string sha256
- a5f4c21c7440e4836a8d3b38dc465d5869d97bcb688cdade3a1615717abfca44
Preserved source evidence · Not medical advice
Triangle